Observational Study of Adults Living with Chronic Hepatitis B in Australia to Monitor Care and Treatment

What this Trial Is About

This observational study focuses on people living with chronic hepatitis B in Australia. It aims to characterize and monitor how individuals link to care and their treatment needs across a wide network of healthcare services. The study is sponsored by the Kirby Institute and seeks to understand various aspects of hepatitis B management in a real-world setting. Participants are individuals diagnosed with chronic hepatitis B who have attended participating clinics for hepatitis B care within the past 12 months or are attending from the study start. There is no intervention as this is an observational study. Data collected includes demographics, lab results, liver disease assessments, treatment history, and clinical management details. Follow-up data will be gathered at each visit or at least every 12 months. During the study, participants will have their hepatitis B treatment and clinical management monitored regularly. Researchers will evaluate outcomes such as hepatitis B disease stage, treatment adherence, liver fibrosis progression, and surveillance for liver cancer. The study plans to collect data until July 2027, with ongoing observation to understand disease progression and care patterns over time.

Real World Assessment of People Living With Chronic Hepatitis B in Australia